A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline
NCT00143299
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
375
Enrollment
INDUSTRY
Sponsor class
Conditions
Smoking Cessation
Interventions
DRUG:
varenicline (CP-526,555)
Sponsor
Pfizer